Care Net ＜2150＞ announced consolidated financial results for the 1st quarter (January to March 24) of the fiscal year ending 2024/12 on the 14th. Sales increased 5.6% from the same period last year to 2,667 billion yen, operating profit decreased 23.7% to 545 million yen, ordinary profit decreased 21.2% to 563 million yen, and quarterly net profit attributable to parent company shareholders decreased 32.1% to 310 million yen.

Sales in the pharmaceutical DX business increased 4.5% from the same period last year to 2,403 billion yen, and operating profit decreased 4.0% from the same period last year to 945 million yen. Sales and profit increased and decreased as efforts such as strengthening the sales system for existing services proceeded.

Sales in the medical platform business increased 17.1% to 265 million yen, and operating profit decreased 65.4% to 122 million yen. Operating profit margins declined due to strengthened sales systems and staff increases for new development, resulting in an increase in sales and a decrease in profit. Sales of the job change support service “Career” etc. for doctors fell 15.2% from the same period to 114 million yen. Meanwhile, with regard to medical education videos and other services, sales increased 63.9% from the same period to 150 million yen due to the new consolidation of Medical Create.

Also, on the medical specialty site “CareNet.com (CareNet.com)” for physicians and health care workers, we have continued to actively invest in the previous fiscal year with the aim of acquiring and maintaining physician members. As a result, the number of physician members at the end of the first quarter was 226,000 (up 6.9% from the same period last year), reaching 230,000 as of 2024/5/14.

Regarding the consolidated earnings forecast for the full year ending 2024/12, the initial plan for the fiscal year ending 2024/12 remains unchanged, with sales rising 13.3% from the previous fiscal year to 11.60 billion yen, operating income falling 9.4% to 2.200 billion yen, ordinary income falling 10.8% to 2.200 billion yen, and net income attributable to parent company shareholders falling 0.7% to 150 billion yen.